{"id":"W2064130493","doi":"10.1056/nejmoa1307684","title":"Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus","year":2013,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":3474,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Saxagliptin; Medicine; Hazard ratio; Myocardial infarction; Internal medicine; Heart failure; Placebo; Stroke (engine); Type 2 diabetes; Unstable angina; Clinical endpoint; Diabetes mellitus; Confidence interval; Randomized controlled trial; Sitagliptin; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}